Literature DB >> 28845502

Transthoracic ultrasonography for the follow-up of a chronic lymphocytic leukemia patient with chemotherapy-induced immunosuppression prior to allogeneic stem cell transplantation. A case report.

Ioana Frinc1, Delia Dima2, Mariana Chitic3, Cristian Berce3, Ioana Berindan-Neagoe4, Tiberiu Tat1, Alina Tanase5, Ciprian Tomuleasa6, Anca Bojan7.   

Abstract

In the last years, significant progress has been made in the clinical follow-up of leukemia patients who are especially prone to various infections because of the specific immunosuppressive state following chemotherapy. The follow-up of such patients is of special interest and is based on modern imaging protocols especially computer tomography (CT). Still, CT may not always be effective in the diagnosing of respiratory infections. We report a chronic lymphocytic leukemia patient in which the pleuro-pulmonary complications were successfully diagnosed and followed up using transthoracic ultrasonography.

Entities:  

Mesh:

Year:  2017        PMID: 28845502     DOI: 10.11152/mu-976

Source DB:  PubMed          Journal:  Med Ultrason        ISSN: 1844-4172            Impact factor:   1.611


  4 in total

1.  Clinical efficacy of platelet transfusion therapy in patients with leukemia and analysis of risk factors for ineffective transfusion.

Authors:  Li Chen; Hao Zhou; Bo Guo; Zheng Guan
Journal:  Oncol Lett       Date:  2020-01-24       Impact factor: 2.967

Review 2.  Continuous renal replacement therapy in cytokine release syndrome following immunotherapy or cellular therapies?

Authors:  Catalin Constantinescu; Sergiu Pasca; Tiberiu Tat; Patric Teodorescu; Catalin Vlad; Sabina Iluta; Delia Dima; Dana Tomescu; Ecaterina Scarlatescu; Alina Tanase; Olafur Eysteinn Sigurjonsson; Anca Colita; Hermann Einsele; Ciprian Tomuleasa
Journal:  J Immunother Cancer       Date:  2020-05       Impact factor: 13.751

3.  The Analysis of the Effect of Blood Transfusion on Changes of Blood Platelet Parameters in Patients with Leukemia Treated with Chemotherapy.

Authors:  Yangxin He; Shanshan Liang; Yali Xu; Chunjing Wan; Feng Ma; Baoyan Wang
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-29       Impact factor: 2.650

4.  Castleman's disease in the HIV-endemic setting.

Authors:  Esam-Rajab Mahroug; Candice Sher-Locketz; Minodora-Silvia Desmirean; Emmanuel-Akinola Abayomi; Ciprian Tomuleasa; Ravnit Grewal
Journal:  Cancer Manag Res       Date:  2018-10-12       Impact factor: 3.989

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.